CBS: slow down the Alzheimer's drug trial hype
Journalists fire "silver bullet" at Alzheimer's & amyloid again
TIME: Simple Test May Predict Alzheimer's
On treatments, tests, products, procedures
Visit each link to hear from patients and doctors about why these matter, and to see Thumbs up and Down story examples.
There are multiple ways to search our reviews. You may search by keyword, news source or review rating.
This story did an efficient job of checking off most of our boxes. We applaud the 5-star score, but we can never resist the temptation to offer a few suggestions for improvement.
This New York Times story did a thorough job explaining the benefits and shortcomings of a series of trials looking into a class of cholesterol drugs. We especially liked how the piece addressed limitations and costs. More informative than the Associated Press coverage of the same studies.
Our review offers a few suggestions for how this story could have been improved, but honestly, we couldn’t come up with much.
The Journal of the American Geriatrics Society published an editorial, “Disease Mongering of Age-Associated Declines in Testosterone and Growth Hormone...
What follows are the third and fourth Alzheimer’s disease news items we’ve reviewed in the last 3 days. This could...
The following is a guest blog post from one of our regular contributors, Alan Cassels, who is an author, journalist,...